Painreform Key Fundamental Indicators

PRFX Stock  USD 3.02  0.18  5.63%   
As of the 12th of February 2026, Painreform holds the Coefficient Of Variation of (1,354), variance of 54.19, and Risk Adjusted Performance of (0.05). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Painreform, as well as the relationship between them.
Painreform's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Painreform's valuation are provided below:
Market Capitalization
1.9 M
Earnings Share
29.9
We have found one hundred twenty available trending fundamental ratios for Painreform, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Painreform recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
At this time, Painreform's Research Development is fairly stable compared to the past year. Total Operating Expenses is likely to rise to about 17.7 M in 2026, whereas Depreciation And Amortization is likely to drop slightly above 13.7 K in 2026.
  
Build AI portfolio with Painreform Stock

Painreform Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total AssetsM5.2 M4.8 M
Slightly volatile
Short and Long Term Debt Total38.5 K40.5 K2.4 M
Slightly volatile
Other Current Liabilities2.5 M2.4 M676.6 K
Slightly volatile
Total Current Liabilities1.9 M2.8 M1.2 M
Slightly volatile
Property Plant And Equipment Net117.1 K111.5 K34.3 K
Slightly volatile
Accounts Payable229.6 K340.4 K158.1 K
Slightly volatile
Cash6.8 M4.9 M3.7 M
Slightly volatile
Non Current Assets Total72.7 K111.5 K42.4 K
Slightly volatile
Cash And Short Term Investments6.8 M4.9 M3.7 M
Slightly volatile
Net Receivables77 K136.8 K53.8 K
Slightly volatile
Common Stock Shares Outstanding21.9 K20.9 K5.3 K
Slightly volatile
Liabilities And Stockholders EquityM5.2 M4.8 M
Slightly volatile
Non Current Liabilities Total221.4 K233.1 K2.1 M
Slightly volatile
Other Current Assets52.4 K55.2 K379.3 K
Slightly volatile
Other Stockholder Equity70.4 M67 M21.4 M
Slightly volatile
Total Liabilities2.4 M2.4 M3.3 M
Slightly volatile
Total Current Assets8.9 M5.1 M4.7 M
Slightly volatile
Common Stock177.5 K169.1 K56.3 K
Slightly volatile
Property Plant Equipment53.1 K50.6 K18.7 K
Slightly volatile
Non Currrent Assets Other231.8 K220.8 K94.9 K
Slightly volatile
Long Term Debt3.6 M4.1 M4.4 M
Slightly volatile
Common Stock Total Equity94.2 K89.7 K36.7 K
Slightly volatile
Other Liabilities228.8 K218.7 K358.9 K
Slightly volatile
Inventory9.4 MM2.7 M
Slightly volatile
Deferred Long Term Liabilities153.6 K172.8 K188.6 K
Slightly volatile
Short and Long Term Debt4.9 M5.6 M6.1 M
Slightly volatile
Short Term Debt77 K81 K3.7 M
Slightly volatile
Property Plant And Equipment Gross87.3 K111.5 K47 K
Slightly volatile
Capital Lease Obligations52.4 K40.5 K78.9 K
Slightly volatile

Painreform Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization13.7 K14.4 K448.4 K
Slightly volatile
Selling General Administrative2.4 M3.4 M1.5 M
Slightly volatile
Research Development14.1 M13.5 M3.4 M
Slightly volatile
Total Operating Expenses17.7 M16.9 MM
Slightly volatile
Cost Of Revenue11.9 K18.4 K5.9 K
Slightly volatile
Reconciled Depreciation11.9 K18.4 K5.9 K
Slightly volatile
Selling And Marketing Expenses52.8 K59.4 K64.8 K
Slightly volatile

Painreform Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation543.7 K356.5 K269.1 K
Slightly volatile
Begin Period Cash Flow6.3 M9.2 M3.8 M
Slightly volatile
Depreciation13.7 K14.4 K63.4 K
Pretty Stable
Capital Expenditures16.2 K14.9 K12.9 K
Pretty Stable
End Period Cash Flow6.9 M4.9 M3.7 M
Slightly volatile
Change To Netincome1.2 M1.9 M864.3 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio40.9446.0550.2637
Slightly volatile
Days Sales Outstanding187210229
Slightly volatile
Stock Based Compensation To Revenue12.9214.5415.8663
Slightly volatile
Capex To Depreciation0.890.930.6404
Slightly volatile
EV To Sales2.833.183.4756
Slightly volatile
Inventory Turnover0.00150.00170.0019
Slightly volatile
Days Of Inventory On Hand152.3 K171.3 K187 K
Slightly volatile
Payables Turnover0.0490.04860.0535
Slightly volatile
Sales General And Administrative To Revenue41.3746.5450.797
Slightly volatile
Research And Ddevelopement To Revenue41.1446.2850.5117
Slightly volatile
Capex To Revenue0.05580.06280.0685
Slightly volatile
Cash Per Share2012111.5 K
Slightly volatile
Days Payables Outstanding6.7 K7.8 K6.9 K
Slightly volatile
Income Quality0.580.780.7445
Pretty Stable
Current Ratio1.551.634.7919
Slightly volatile
Receivables Turnover1.251.411.5361
Slightly volatile
Capex Per Share0.780.825.6912
Very volatile
Revenue Per Share38.7243.5647.5425
Slightly volatile
Interest Debt Per Share3.553.741.2 K
Slightly volatile
Debt To Assets0.01090.011411.7523
Slightly volatile
Operating Cycle152.5 K171.5 K187.2 K
Slightly volatile
Days Of Payables Outstanding6.7 K7.8 K6.9 K
Slightly volatile
Ebt Per Ebit1.521.141.3311
Very volatile
Long Term Debt To Capitalization47.4764.5758.2209
Slightly volatile
Total Debt To Capitalization0.02630.027726.9746
Slightly volatile
Quick Ratio1.551.634.2345
Pretty Stable
Net Income Per E B T1.311.151.4864
Slightly volatile
Cash Ratio1.491.573.7409
Pretty Stable
Days Of Inventory Outstanding152.3 K171.3 K187 K
Slightly volatile
Days Of Sales Outstanding187210229
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0179
Slightly volatile
Fixed Asset Turnover1.561.761.9199
Slightly volatile
Debt Ratio0.01090.011411.7523
Slightly volatile
Price Sales Ratio40.9446.0550.2637
Slightly volatile
Asset Turnover0.00560.00630.0069
Slightly volatile
Gross Profit Margin0.660.740.8108
Slightly volatile

Painreform Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.5 MM4.3 M
Slightly volatile
Enterprise Value243.4 K273.9 K298.9 K
Slightly volatile

Painreform Fundamental Market Drivers

Painreform Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Painreform Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Painreform is extremely important. It helps to project a fair market value of Painreform Stock properly, considering its historical fundamentals such as Return On Equity. Since Painreform's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Painreform's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Painreform's interrelated accounts and indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Painreform. Anticipated expansion of Painreform directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Painreform assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
29.9
Return On Assets
(0.36)
Return On Equity
(1.28)
Investors evaluate Painreform using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Painreform's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Painreform's market price to deviate significantly from intrinsic value.
It's important to distinguish between Painreform's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Painreform should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Painreform's market price signifies the transaction level at which participants voluntarily complete trades.

Painreform 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Painreform's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Painreform.
0.00
11/14/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/12/2026
0.00
If you would invest  0.00  in Painreform on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Painreform or generate 0.0% return on investment in Painreform over 90 days. Painreform is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that prov... More

Painreform Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Painreform's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Painreform upside and downside potential and time the market with a certain degree of confidence.

Painreform Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Painreform's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Painreform's standard deviation. In reality, there are many statistical measures that can use Painreform historical prices to predict the future Painreform's volatility.
Hype
Prediction
LowEstimatedHigh
0.153.0510.52
Details
Intrinsic
Valuation
LowRealHigh
0.265.2312.70
Details
1 Analysts
Consensus
LowTargetHigh
10.9212.0013.32
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Painreform. Your research has to be compared to or analyzed against Painreform's peers to derive any actionable benefits. When done correctly, Painreform's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Painreform.

Painreform February 12, 2026 Technical Indicators

Painreform Backtested Returns

Painreform maintains Sharpe Ratio (i.e., Efficiency) of -0.0412, which implies the firm had a -0.0412 % return per unit of risk over the last 3 months. Painreform exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Painreform's Risk Adjusted Performance of (0.05), variance of 54.19, and Coefficient Of Variation of (1,354) to confirm the risk estimate we provide. The company holds a Beta of 1.84, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Painreform will likely underperform. At this point, Painreform has a negative expected return of -0.31%. Please make sure to check Painreform's standard deviation, potential upside, as well as the relationship between the Potential Upside and price action indicator , to decide if Painreform performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.67  

Good predictability

Painreform has good predictability. Overlapping area represents the amount of predictability between Painreform time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Painreform price movement. The serial correlation of 0.67 indicates that around 67.0% of current Painreform price fluctuation can be explain by its past prices.
Correlation Coefficient0.67
Spearman Rank Test0.01
Residual Average0.0
Price Variance0.38
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Painreform Total Stockholder Equity

Total Stockholder Equity

1.99 Million

At this time, Painreform's Total Stockholder Equity is fairly stable compared to the past year.
Based on the latest financial disclosure, Painreform has a Return On Equity of -1.2765. This is 94.67% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Painreform Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Painreform's current stock value. Our valuation model uses many indicators to compare Painreform value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Painreform competition to find correlations between indicators driving Painreform's intrinsic value. More Info.
Painreform is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers . At this time, Painreform's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Painreform's earnings, one of the primary drivers of an investment's value.

Painreform Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Painreform's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Painreform could also be used in its relative valuation, which is a method of valuing Painreform by comparing valuation metrics of similar companies.
Painreform is currently under evaluation in return on equity category among its peers.

Painreform ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Painreform's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Painreform's managers, analysts, and investors.
Environmental
Governance
Social

Painreform Fundamentals

About Painreform Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Painreform's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Painreform using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Painreform based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue18.4 K11.9 K
Stock Based Compensation To Revenue 14.54  12.92 
Sales General And Administrative To Revenue 46.54  41.37 
Research And Ddevelopement To Revenue 46.28  41.14 
Capex To Revenue 0.06  0.06 
Revenue Per Share 43.56  38.72 
Ebit Per Revenue(92.82)(97.46)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Painreform Stock Analysis

When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.